Table 1. Baseline demographic information for patients prescribed SOF/LED from Yale non-transplant hepatology and transplant hepatology clinics from October 1, 2014 to December 30, 2014 (n = 129).
| Characteristic | Value | |
|---|---|---|
| Age in years, mean ± SD | 57.0 ± 9.9 | |
| Gender, n (%) | Male | 79 (61.2) |
| Female | 50 (38.8) | |
| Race, n (%) | White | 88 (68.2) |
| Black | 25 (19.4) | |
| Asian | 4 (3.1) | |
| Other | 11 (8.5) | |
| Unknown | 1 (0.8) | |
| Ethnicity, n (%) | Non-Hispanic | 106 (82.2) |
| Hispanic | 21 (16.3%) | |
| Patient refused/Unk | 2 (1.6%) | |
| Medical insurance, n (%) | Private | 63 (49.2) |
| Public | 64 (50.0) | |
| Unknown / None | 1 (0.8) | |
| Smoking History, n (%) | Non-smoker | 29 (22.5) |
| Prior smoker | 54 (41.9) | |
| Active smoker | 39 (30.2) | |
| Unknown | 7 (5.4%) | |
| Alcohol use history, n (%) | Never | 36 (27.9) |
| Occasional | 29 (22.5) | |
| Prior abuse | 42 (32.6%) | |
| Unknown | 22 (17.1%) | |
| Illicit drug use history, n (%) | Never | 37 (28.7) |
| Prior use | 68 (52.7) | |
| Active use | 6 (4.7) | |
| Unknown | 18 (14.0) | |
| Body mass index, mean ± SD | 29.0 ± 6.4 | |
| Diabetes mellitus, n (%) | 31 (24.0) | |
| Hypertension, n (%) | 58 (45.0) | |
| Psychiatric history, n (%) | 50 (38.8) | |
| HBV, n (%) | 0 (0) | |
| HIV, n (%) | 3 (2.3) | |
| GFR, no (%) | >60 | 115 (89.2) |
| ≤60 | 14 (10.9) | |
| Followed in transplant clinic, n (%) | 34 (26.4) | |